Philip Toleikis
Corporate Officer/Principal bei Medway Working Group
Vermögen: 1 Mio $ am 31.05.2024
Aktive Positionen von Philip Toleikis
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Medway Working Group | Corporate Officer/Principal | - | - |
Karriereverlauf von Philip Toleikis
Ehemalige bekannte Positionen von Philip Toleikis
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SERNOVA CORP. | Direktor/Vorstandsmitglied | 19.10.2010 | 30.04.2024 |
| Vorstandsvorsitzender | 28.04.2009 | 05.09.2023 | |
| Technik-/Wissenschafts-/F&E-Leiter | 05.09.2023 | 30.04.2024 | |
| Investor Relations Kontakt | - | 28.07.2014 | |
| Public Communications Contact | 19.10.2010 | 28.07.2014 | |
| Präsident | 28.04.2009 | 05.09.2023 | |
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2006 | 01.01.2006 |
Ausbildung von Philip Toleikis
| University of British Columbia | Doctorate Degree |
| University of Michigan | Graduate Degree |
| University of Vermont | Undergraduate Degree |
Statistik
International
| Kanada | 5 |
| Vereinigte Staaten | 3 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SERNOVA CORP. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
| Medway Working Group |
- Börse
- Insiders
- Philip Toleikis
- Erfahrung
